GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NuGen Medical Devices Inc (TSXV:NGMD) » Definitions » Capital Expenditure

NuGen Medical Devices (TSXV:NGMD) Capital Expenditure : C$0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is NuGen Medical Devices Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

NuGen Medical Devices's cash flow for capital expenditures for the three months ended in Dec. 2024 was C$0.00 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2024 was C$0.00 Mil.

NuGen Medical Devices Capital Expenditure Historical Data

The historical data trend for NuGen Medical Devices's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NuGen Medical Devices Capital Expenditure Chart

NuGen Medical Devices Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure
-0.01 - - - -0.01

NuGen Medical Devices Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

NuGen Medical Devices Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NuGen Medical Devices Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NuGen Medical Devices Inc (TSXV:NGMD) » Definitions » Capital Expenditure
Comparable Companies
TSXV:FREQ TSXV:CNVI TSXV:VPT TSXV:MDX TSXV:THRM XCNQ:PMED TSXV:ZCT TSXV:ASG XCNQ:MYTC XCNQ:ASTI ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD
Traded in Other Exchanges
NGMDF:USA 79O:Germany
Address
18 King Street East, Suite 1400, Toronto, ON, CAN, M5C 1C4
Website
https://www.nugenmd.com
NuGen Medical Devices Inc is a medical device manufacturing company specializing in the field of needleless injections and related technologies. The reportable segment of the company is the manufacturing of needle injector devices. Geographically, the company generates revenue from Europe, followed by Asia, North America, and other.
Executives
Tony Di Benedetto Director, Senior Officer
Richard Buzbuzian Director, Senior Officer
M. William Cleman Director
Michael G. Wright Director, Senior Officer
Michael A. Wekerle Director

NuGen Medical Devices Headlines

No Headlines